Results 141 to 150 of about 225,763 (291)
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki+11 more
wiley +1 more source
Coronary disease: Acute coronary syndromes: risk stratification [PDF]
Adam Timmis
openalex +1 more source
The ENACT study: a pan-European survey of acute coronary syndromes [PDF]
Keith A.A. Fox
openalex +1 more source
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro+15 more
wiley +1 more source
Background Microplastics, widely present in the environment, are implicated in disease pathogenesis through oxidative stress and immune modulation. Prevailing research, primarily based on animal and cell studies, falls short in elucidating microplastics'
Yunxiao Yang+10 more
doaj +1 more source
Randomized, Double‐blind, Placebo‐controlled Trial of Diazepam, Nitroglycerin, or Both for Treatment of Patients with Potential Cocaine‐associated Acute Coronary Syndromes [PDF]
Brigitte M. Baumann+4 more
openalex +1 more source
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia+2 more
wiley +1 more source
Associated Factors of Anxiety among Acute Coronary Syndrome Patients in Kelantan and Terengganu
Background and purpose: Anxiety is a common condition among acute coronary syndrome patients. This syndrome often goes unrecognised and can persist for months to years, while impacting substantially the quality of life.
Wan Adnan Wan-Nor-Asyikeen+3 more
doaj
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT [PDF]
K. Martijn Akkerhuis
openalex +1 more source